Tuwawa, Rey L.
HRN: 04-95-78 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2023
CEFAZOLIN 1GM (VIAL)
05/30/2023
06/06/2023
IV
1g
Q8h
Lacerated Wound On Face And Scalp
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes